August 20, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Brian Farmer, CEO of Inipharm
In this Q&A, Farmer discusses the genetic discovery that inspired Inipharm's approach, why an oral small-molecule strategy sets the company apart from RNA-based competitors, early clinical signals behind INI-822, and what it takes to build a small team capable of advancing a novel drug target. More

Press Releases

  • Regeneron: Pasatru (garetosmab-grts) First and Only FDA-approved Treatment Demonstrating Reduction in New Heterotopic Ossification (HO) Lesions and Clinician-Assessed Flare-ups in a Placebo-controlled Trial in Adults With Fibrodysplasia Ossificans Progressiva (FOP) More More More* More*
  • Soft Bones: Calls for Improved Treatment Access for HPP Patients in Korea More
  • Taiho Oncology and Cullinan Therapeutics: Zipalertinib Plus Chemotherapy First-Line Phase 3 REZILIENT3 Trial Data Selected for Presidential Symposium Presentation at the IASLC 2026 World Conference on Lung Cancer More
  • Teva: U.S. FDA Accepts New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients With Tourette Syndrome More
  • Vascarta: NIH Phase I Clinical Study of Vas-101 in Sickle Cell Disease Begins More

Financial News

  • Big4Bio: On Your Mark Returns for JPM Week 2027, With a Live Site Alongside the Guide More
  • BioPharmCatalyst Weekly Watchlist: Key PDUFAs Left for the Quarter More
  • Intelligent Bio Solutions: Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth More
  • InterCure: 1-for-5 Reverse Share Split More
  • UroGen: Strategic Collaboration and Investment Agreements With IntraGel to Access Biodegradable Sustained-Release Gel Platform and Expand Oncology Pipeline More

Media/Misc Coverage

  • Big4Bio CEO Weekly Q&A: Brian Farmer, CEO of Inipharm More
  • Biotech & Pharma Updates | August 19 More
  • Human Multi-Organ Chip Offers New Insight Into Cancer Metastasis More
  • More on Moderna’s Personalized Cancer Vaccine Showing Success in Phase 3 Trial More* More* More More
  • Subscribe to LifeSci Startup for Updates on US Startups More
Cyprotex - An Evotec Company | Your trusted ADME-Tox partner. Discovery Bioanalysis. Tailored for the molecules that matter most. 1. Peptide therapeutics, 2. Endogenous biomarkers, 3. Complex small molecules. Learn more >

Career Moves

Telling Your Science Story to Investors
Learn More  →
  • 11 Companies Hiring in New Jersey More
  • OPPORTUNITY: Chief Operating Officer, Remote More
  • OPPORTUNITY: Computational Scientist, New York More
  • OPPORTUNITY: Head of Computational Method Development, Boston More
  • 7 Biopharma M&A Deals Where Layoffs Followed More
  • Slone Partners: Fractional Leadership in Biotech and Life Sciences - When it Works and Why More
  • Slone Partners: Places Farhad Ghavami as Chief Executive Officer at SeqCenter More

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: BioFuture Oct 27-28
Learn More  →

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: NYC Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

NYC Sponsors

Follow us


Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:NYC, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.